Li‐Ru You
- Hepatology top 2%
- Hepatitis C virus research 4
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ 4
- Molecular Biology top 5%
- Congenital heart defects research 4
- Wnt/β-catenin signaling in development and cancer 4
- Muscle Physiology and Disorders 3
- Ubiquitin and proteasome pathways 3
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 3
- Neurology top 5%
-
- Hepatitis B Virus Studies 3
Li‐Ru You
38 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 94
- Hepatology 362
- Cell Biology 407
- Molecular Biology 1.3k
- Cancer Research 232
- Neurology 198
Countries citing papers authored by Li‐Ru You
This map shows the geographic impact of Li‐Ru You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Ru You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Ru You more than expected).
Fields of papers citing papers by Li‐Ru You
This network shows the impact of papers produced by Li‐Ru You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Ru You. The network helps show where Li‐Ru You may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li‐Ru You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 3 | |
| 4 | 2019 | 6 | |
| 5 | 2018 | 32 | |
| 6 | 2017 | 8 | |
| 7 | 2016 | 59 | |
| 8 | 2014 | 47 | |
| 9 | 2013 | 15 | |
| 10 | 2013 | 86 | |
| 11 | 2012 | 12 | |
| 12 | 2011 | 26 | |
| 13 | 2010 | 14 | |
| 14 | 2010 | 254 | |
| 15 | 2009 | 27 | |
| 16 | 2007 | 93 | |
| 17 | 2007 | 24 | |
| 18 | 2005 | 498 | |
| 19 | 2002 | 123 | |
| 20 | 2000 | 70 |
About Li‐Ru You
Li‐Ru You is a scholar working on Hepatology, Cell Biology and Molecular Biology, having authored 38 papers that have together received 2.2k indexed citations. Recurring topics across this work include Congenital heart defects research (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Hepatitis C virus research (4 papers), Muscle Physiology and Disorders (3 papers), Ubiquitin and proteasome pathways (3 papers), Hepatitis B Virus Studies (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Hepatology (362 citations), Cell Biology (407 citations) and Molecular Biology (1.3k citations). Li‐Ru You has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Chun‐Ming Chen, Yan‐Hwa Wu Lee, Sophia Y. Tsai, Ming‐Jer Tsai, Francesco J. DeMayo, Fu‐Jung Lin, Christopher T. Lee, Filippo G. Giancotti, Tomoyo Okada and L H Hwang. Their work appears in journals such as Journal of Virology, Scientific Reports, Human Molecular Genetics, American Journal Of Pathology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.